AbbVie Inc (NYSE:ABBV) will be reporting its third-quarter earnings on Wednesday. Wall Street expects $2.92 in EPS and $14.28 billion in revenues as the company reports before market hours. Ahead of ...
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results